Germany Pharmaceutical and Medical Goods Expenditure Share (2023)
Germany's Pharmaceutical and Medical Goods Expenditure Share: 18.1 % of current health expenditure in 2023, +0.4pp YoY.
Germany (2023)
18.1
% of current health expenditure
+0.4pp YoY
YoY Change
+0.4pp
percentage points
Trend
up
Series length
8
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2023 | 18.1 | +0.4pp |
| 2022 | 17.7 | -1pp |
| 2021 | 18.7 | +0.3pp |
| 2020 | 18.4 | -0.4pp |
| 2019 | 18.8 | -0.5pp |
| 2018 | 19.3 | -0.1pp |
| 2017 | 19.4 | -0.5pp |
| 2016 | 19.9 | n/a |
About this Dataset
Germany recorded 18.1 % of current health expenditure in 2023. The latest change was +0.4pp. Across 2016–2023 the series ranges from 17.7 in 2022 to 19.9 in 2016.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Germany.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Germany. It is published by Eurostat and updated annually.
The most recent observation covers 2023. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2016–2023 (8 observations).
The series peaked at 19.9 % of current health expenditure in 2016 and reached its lowest recorded value of 17.7 in 2022. The latest reading of 18.1 in 2023 represents a change of +0.4pp.